Deletion of cationic amino acid transporter 2 exacerbates dextran sulfate sodium colitis and leads to an IL-17-predominant T cell response

Kshipra Singh1, Lori A. Coburn1,2, Daniel P. Barry1,2, Mohammad Asim1,2, Brooks Scull1, Margaret M. Allaman1,2, Nuruddeen D. Lewis3,1, M. Kay Washington4, Michael J. Rosen5, Christopher S. Williams3,1,2, Rupesh Chaturvedi1, Keith T. Wilson3,4,1,2
1Division of Gastroenterology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee;
2Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee
3Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee
4Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee
5Division of Gastroenterology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee; and

Tóm tắt

l-Arginine (l-Arg) is a semiessential amino acid that has altered availability in human ulcerative colitis (UC), a form of inflammatory bowel disease, and is beneficial in murine colitis induced by dextran sulfate sodium (DSS), a model with similarity to UC. We assessed the role of cationic amino acid transporter 2 (CAT2), the inducible transporter of l-Arg, in DSS colitis. Expression of CAT2 was upregulated in tissues from colitic mice and localized predominantly to colonic macrophages. CAT2-deficient (CAT2−/−) mice exposed to DSS exhibited worsening of survival, body weight loss, colon weight, and histological injury. These effects were associated with increased serum l-Arg and decreased tissue l-Arg uptake and inducible nitric oxide synthase protein expression. Clinical benefits of l-Arg supplementation in wild-type mice were lost in CAT2−/−mice. There was increased infiltration of macrophages, dendritic cells, granulocytes, and T cells in colitic CAT2−/−compared with wild-type mice. Cytokine profiling revealed increases in proinflammatory granulocyte colony-stimulating factor, macrophage inflammatory protein-1α, IL-15, and regulated and normal T cell-expressed and -secreted and a shift from an IFN-γ- to an IL-17-predominant T cell response, as well as an increase in IL-13, in tissues from colitic CAT2−/−mice. However, there were no increases in other T helper cell type 2 cytokines, nor was there a global increase in macrophage-derived proinflammatory cytokines. The increase in IL-17 derived from both CD4 and γδ T cells and was associated with colonic IL-6 expression. Thus CAT2 plays an important role in controlling inflammation and IL-17 activation in an injury model of colitis, and impaired l-Arg availability may contribute to UC pathogenesis.

Từ khóa


Tài liệu tham khảo

10.3109/10715762.2012.756980

Aoki Y, 2000, J Leukoc Biol, 68, 757, 10.1189/jlb.68.5.757

10.1371/journal.pone.0029046

10.1016/S0140-6736(07)60750-8

10.1016/S0140-6736(07)60751-X

10.1016/j.coi.2005.11.007

10.1152/ajpcell.00165.2002

10.1053/j.gastro.2010.06.060

10.1128/IAI.00578-07

10.1074/jbc.M401370200

10.1007/s00726-011-1038-4

10.1073/pnas.212290499

10.1006/niox.1996.0106

Closs EI, 2000, Mol Pharmacol, 57, 68

10.1371/journal.pone.0033546

10.1038/mi.2011.54

10.1038/nri2800

10.1084/jem.179.5.1689

10.1016/0016-5085(94)90803-6

10.4049/jimmunol.170.9.4457

Doherty TM, 1996, J Immunol, 156, 735, 10.4049/jimmunol.156.2.735

10.1136/gut.52.1.65

10.1172/JCI19836

10.1038/nm.2391

10.1056/NEJMoa020732

10.4049/jimmunol.173.3.2109

10.1126/science.8178155

10.1038/ni1254

10.1002/ibd.21035

10.1016/j.bbrc.2008.09.019

10.1111/j.1365-2249.2006.03214.x

10.1126/science.2524098

10.1042/bj3400549

10.3748/wjg.v12.i2.302

10.1084/jem.194.9.1207

10.1172/JCI200215256

10.1189/jlb.1105696

10.4049/jimmunol.1003431

10.4049/jimmunol.0902436

10.1038/ni.1610

10.4049/jimmunol.167.3.1179

10.1016/j.biocel.2003.10.019

10.1016/S0165-5728(97)00040-4

10.1074/jbc.M010030200

Nicola NA, 1983, J Biol Chem, 258, 9017, 10.1016/S0021-9258(18)32158-6

10.1186/1465-9921-11-87

10.1111/j.1365-2249.1995.tb03130.x

10.1016/j.clim.2003.09.013

10.1016/0016-5085(90)90290-H

10.4049/jimmunol.1101052

10.1002/ibd.21896

10.1017/S0007114512001122

10.4049/jimmunol.179.8.5576

10.1016/j.coi.2008.03.006

10.4049/jimmunol.1201373

10.1136/gut.2009.182170

10.1002/eji.200324545

10.1056/NEJMoa050516

10.1056/NEJMoa043335

10.1053/j.gastro.2008.07.014

Schall TJ, 1988, J Immunol, 141, 1018, 10.4049/jimmunol.141.3.1018

10.4049/jimmunol.178.7.4466

10.1074/jbc.M710530200

10.1074/jbc.M110.176719

10.1152/ajpgi.00544.2011

10.1126/science.2420009

10.1002/eji.201242569

10.1111/j.1365-2249.2009.03934.x

10.1165/ajrcmb/4.2.140

10.1371/journal.ppat.1000023

10.4049/jimmunol.171.10.5507

10.1007/s00424-003-1086-z

10.1073/pnas.90.2.587

Williams CS, Gut

10.1136/gut.2005.076000